ZBTB43 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.791400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.007000E-01
Normal-vs-Stage2
5.958000E-01
Normal-vs-Stage3
1.401750E-01
Normal-vs-Stage4
9.298200E-01
Stage1-vs-Stage2
7.923200E-01
Stage1-vs-Stage3
2.186400E-01
Stage1-vs-Stage4
3.728600E-01
Stage2-vs-Stage3
1.839570E-01
Stage2-vs-Stage4
6.047200E-01
Stage3-vs-Stage4
1.428440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.566200E-01
Normal-vs-AfricanAmerican
5.495800E-01
Normal-vs-Asian
9.177800E-01
Caucasian-vs-AfricanAmerican
8.866800E-01
Caucasian-vs-Asian
4.026400E-01
AfricanAmerican-vs-Asian
5.825400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.558400E-01
Normal-vs-Female
4.720400E-01
Male-vs-Female
6.628400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.457400E-01
Normal-vs-Age(41-60Yrs)
9.846600E-01
Normal-vs-Age(61-80Yrs)
4.723200E-01
Normal-vs-Age(81-100Yrs)
3.299900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.813800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.553600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.621400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.804900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.563400E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.480000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.881000E-01
Normal-vs-Daily Drinker
3.481000E-01
Normal-vs-Weekly Drinker
5.305600E-01
Normal-vs-Occasional Drinker
5.812600E-01
Normal-vs-Social Drinker
7.647800E-01
Non Drinker-vs-Daily Drinker
8.647800E-01
Non Drinker-vs-Weekly Drinker
8.255800E-01
Non Drinker-vs-Occasional Drinker
5.530800E-01
Non Drinker-vs-Social Drinker
3.878400E-01
Daily Drinker-vs-Weekly Drinker
6.913400E-01
Daily Drinker-vs-Occasional Drinker
4.035400E-01
Daily Drinker-vs-Social Drinker
2.658800E-01
Weekly Drinker-vs-Occasional Drinker
7.468800E-01
Weekly Drinker-vs-Social Drinker
5.493000E-01
Occasional Drinker-vs-Social Drinker
7.187200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.408440E-01
Normal-vs-Grade 2
6.007900E-02
Normal-vs-Grade 3
1.863900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.429450E-01
Grade 1-vs-Grade 3
6.708800E-01
Grade 1-vs-Grade 4
1.408440E-01
Grade 2-vs-Grade 3
1.160430E-01
Grade 2-vs-Grade 4
6.007900E-02
Grade 3-vs-Grade 4
1.863900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.726400E-01
Normal-vs-NonDiabetic
6.124000E-01
Diabetic-vs-NonDiabetic
5.441200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.309800E-01
Normal-vs-NoPancreatitis
5.906000E-01
Pancreatitis-vs-NoPancreatitis
8.601800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.316400E-01
Normal-vs-N1
6.331000E-01
N0-vs-N1
4.600000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.561000E-01
Normal-vs-TP53-NonMutant
6.381400E-01
TP53-Mutant-vs-TP53-NonMutant
5.044600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
